Literature DB >> 10217521

Evidence for in vitro expression of B1 receptor in the mouse trachea and urinary bladder.

M Trevisani1, F Schmidlin, M Tognetto, F P Nijkamp, J P Gies, N Frossard, S Amadesi, G Folkerts, P Geppetti.   

Abstract

1. Motor responses to des-Arg9-bradykinin and bradykinin were studied in the isolated mouse trachea (precontracted with carbachol, 10 microM) and the urinary bladder of either Swiss, C57B1/6J or bradykinin B2 receptor knockout (Bk2r(-/-)) mice after 1-6 h in vitro. The expression of mRNA for the mouse B1 receptor in tracheal and urinary bladder tissues was also studied by using Northern blot analysis. 2. In isolated tracheae, des-Arg9-bradykinin produced a relaxant response that increased over time: no response was observed after 1 h of incubation, whereas after 6 h the maximum response (1 microM) was 68-84% of the relaxation produced by isoproterenol (1 microM) in the three mouse strains. The relaxant response to bradykinin (1 microM) observed at 1 h (38-51% of isoproterenol) was increased (62-65% of isoproterenol) after 6 h in Swiss and C57B1/6J mice, but was absent in Bk2r(-/-) mice. In the presence of cycloheximide, des-Arg9-bradykinin did not cause any response at 6 h. 3. Similar findings were obtained in the urinary bladder: at 1 h des-Arg9-bradykinin (1 microM) did not cause any motor effect, whereas at 6 h it caused a contraction that was 28-59% of that produced by carbachol (1 microM) in the three mouse strains. Cycloheximide blocked the response to des-Arg9-bradykinin. Bradykinin (1 microM) contracted urinary bladders at 1 h (34-35% of carbachol), as well as at 6 h (66-77% of carbachol) in Swiss and C57B1/6J strains, but was without effect in Bk2r(-/-) mice. 4. Northern blot hybridization with a specific cDNA probe against mouse B1 receptor mRNA using total RNA extracted from tracheae and urinary bladders freshly removed from Swiss and Bk2r(-/-) mice revealed minimal expression. However, marked hybridization was detected 150 min after in vitro exposure in both tissues. 5. Evidence is provided that in vitro exposure of mouse trachea and urinary bladder causes a time-dependent induction of B1 receptors that cause relaxation and contraction, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217521      PMCID: PMC1565899          DOI: 10.1038/sj.bjp.0702410

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Kinin B1 and B2 receptors in the mouse.

Authors:  S N Allogho; F Gobeil; L H Pheng; X K Nguyen-Le; W Neugebauer; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1995-12       Impact factor: 2.273

2.  Effects of kinins on isolated stomachs of control and transgenic knockout B2 receptor mice.

Authors:  S Nsa Allogho; F Gobeil; S I Perron; J F Hess; D Regoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-03       Impact factor: 3.000

3.  Receptors for bradykinin in rabbit aortae.

Authors:  D Regoli; J Barabé; W K Park
Journal:  Can J Physiol Pharmacol       Date:  1977-08       Impact factor: 2.273

4.  Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression.

Authors:  X Zhou; P Polgar; L Taylor
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

5.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Authors:  J P Schanstra; E Bataillé; M E Marin Castaño; Y Barascud; C Hirtz; J B Pesquero; C Pecher; F Gauthier; J P Girolami; J L Bascands
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.

Authors:  R M Vianna; J B Calixto
Journal:  Br J Pharmacol       Date:  1998-01       Impact factor: 8.739

7.  Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury.

Authors:  J F Larrivée; D R Bachvarov; F Houle; J Landry; J Huot; F Marceau
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

8.  Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.

Authors:  L Li; K Vaali; I Paakkari; H Vapaatalo
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

9.  Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells.

Authors:  F Schmidlin; D Scherrer; L Daeffler; C Bertrand; Y Landry; J P Gies
Journal:  Mol Pharmacol       Date:  1998-06       Impact factor: 4.436

10.  Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide.

Authors:  M Figini; F L Ricciardolo; P Javdan; F P Nijkamp; C Emanueli; P Pradelles; G Folkerts; P Geppetti
Journal:  Am J Respir Crit Care Med       Date:  1996-03       Impact factor: 21.405

View more
  4 in total

1.  In vitro measurements of tracheal constriction using mice.

Authors:  Iurii Semenov; Jeremiah T Herlihy; Robert Brenner
Journal:  J Vis Exp       Date:  2012-06-25       Impact factor: 1.355

2.  Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.

Authors:  Bikramjit Chopra; Stacey R Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; William C de Groat; Lori A Birder
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

3.  Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice.

Authors:  Jadranka Eric; Bichoy H Gabra; Pierre Sirois
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues.

Authors:  P R Wille; R Vitor; N H Gabilan; M Nicolau
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.